Signaling Pathway
Opicinumab (BIIB033) is a monoclonal antibody specifically targeting LINGO-1, a protein implicated in the inhibition of axonal regeneration and myelination. This antibody is under investigation for its potential therapeutic applications in treating acute optic neuritis as well as relapsing forms of multiple sclerosis, aiming to enhance neuronal repair and improve neurological function.
重要通知：仅供研究使用。我们不向患者销售。
| Discription | Opicinumab (BIIB033) is a monoclonal antibody specifically targeting LINGO-1, a protein implicated in the inhibition of axonal regeneration and myelination. This antibody is under investigation for its potential therapeutic applications in treating acute optic neuritis as well as relapsing forms of multiple sclerosis, aiming to enhance neuronal repair and improve neurological function. |
||
|---|---|---|---|
| Targets |
|
Calculate the dilution required to prepare a stock solution. This equation is commonly abbreviated as: C1V1 = C2V2
